etomidate has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creagh, O; Crespo, MJ; Cruz, N; Marrero, M; Quidgley, J; Rivera, K; Torres, H | 1 |
| Altinoz, E; Ates, O; Cakir, CO; Cayli, SR; Kocak, A; Turkoz, Y; Yologlu, S; Yucel, N | 1 |
2 other study(ies) available for etomidate and Alloxan Diabetes
| Article | Year |
|---|---|
Diabetes alters cardiovascular responses to anaesthetic induction agents in STZ-diabetic rats.
Topics: Anesthetics; Animals; Blood Glucose; Cardiac Output; Diabetes Complications; Diabetes Mellitus, Experimental; Etomidate; Heart Rate; Hemodynamics; Injections, Intraperitoneal; Ketamine; Propofol; Rats; Rats, Sprague-Dawley; Stroke Volume | 2011 |
Neuroprotective effect of etomidate in the central nervous system of streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Central Nervous System; Diabetes Mellitus, Experimental; Etomidate; Glutathione; Male; Malondialdehyde; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar; Streptozocin; Xanthine Oxidase | 2006 |